129 related articles for article (PubMed ID: 16007029)
21. Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings.
Fasullo S; Cannizzaro S; Maringhini G; Ganci F; Giambanco F; Vitale G; Pinto V; Migliore G; Torres D; Sarullo FM; Paterna S; Di Pasquale P
J Card Fail; 2009 Dec; 15(10):856-63. PubMed ID: 19944362
[TBL] [Abstract][Full Text] [Related]
22. Esmolol facilitated extubation in a patient with severe systolic dysfunction following myocardial infarction.
Karavidas A; Lazaros G; Arapi S; Griva X; Matsakas E
Hellenic J Cardiol; 2007; 48(6):380-4. PubMed ID: 18196664
[TBL] [Abstract][Full Text] [Related]
23. Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?
Cioffi G; De Feo S; Pulignano G; Del Sindaco D; Tarantini L; Stefenelli C; Opasich C
Int J Cardiol; 2006 Feb; 107(2):220-4. PubMed ID: 16412800
[TBL] [Abstract][Full Text] [Related]
24. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Weir R; McMurray JJ
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
[TBL] [Abstract][Full Text] [Related]
25. Does carvedilol have antiarrhythmic properties?
Naccarelli GV
Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):338-9. PubMed ID: 16265556
[No Abstract] [Full Text] [Related]
26. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
Iraqi W; Rossignol P; Angioi M; Fay R; Nuée J; Ketelslegers JM; Vincent J; Pitt B; Zannad F
Circulation; 2009 May; 119(18):2471-9. PubMed ID: 19398668
[TBL] [Abstract][Full Text] [Related]
27. Ventricular remodeling in heart failure and the effect of beta-blockade.
Udelson JE
Am J Cardiol; 2004 May; 93(9A):43B-8B. PubMed ID: 15144937
[TBL] [Abstract][Full Text] [Related]
28. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
[TBL] [Abstract][Full Text] [Related]
29. Patterns of use and potential impact of early beta-blocker therapy in non-ST-elevation myocardial infarction with and without heart failure: the Global Registry of Acute Coronary Events.
Emery M; López-Sendón J; Steg PG; Anderson FA; Dabbous OH; Scheuble A; Eagle KA;
Am Heart J; 2006 Dec; 152(6):1015-21. PubMed ID: 17161045
[TBL] [Abstract][Full Text] [Related]
30. Switching to evidence-based once-daily beta-blockers for improved adherence to medication across the continuum of post-myocardial infarction left ventricular dysfunction and heart failure.
Abraham WT
Congest Heart Fail; 2008; 14(5):272-80. PubMed ID: 18983291
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.
Packer M; Lukas MA; Tenero DM; Baidoo CA; Greenberg BH;
Am J Cardiol; 2006 Oct; 98(7A):39L-45L. PubMed ID: 17023231
[TBL] [Abstract][Full Text] [Related]
32. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
[TBL] [Abstract][Full Text] [Related]
33. [Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies].
Pfeffer MA; Braunvald Iu; Moĭe LA; Basta L; Braun EDzh ; Kaddi TE; Dévis BR; Geltman EM; Goldman S; Fleĭker GS
Kardiologiia; 1993; 33(12):14-23, 3. PubMed ID: 7910865
[TBL] [Abstract][Full Text] [Related]
34. [The use of a beta-blocker esmolol in patients with acute myocardial infarction treated with streptokinase].
Shalaev SV; Bukhvalov VA; Petrik ES; Shabalkov EA
Kardiologiia; 2002; 42(6):4-7. PubMed ID: 12494123
[TBL] [Abstract][Full Text] [Related]
35. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
36. Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or both.
Shin SH; Hung CL; Uno H; Hassanein AH; Verma A; Bourgoun M; Køber L; Ghali JK; Velazquez EJ; Califf RM; Pfeffer MA; Solomon SD;
Circulation; 2010 Mar; 121(9):1096-103. PubMed ID: 20176989
[TBL] [Abstract][Full Text] [Related]
37. Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN).
Colucci WS
Am J Cardiol; 2004 May; 93(9A):13B-6B. PubMed ID: 15144931
[TBL] [Abstract][Full Text] [Related]
38. From left ventricular dysfunction to heart failure.
Cleland JG
Arch Mal Coeur Vaiss; 1996 Nov; 89(11):1397-402. PubMed ID: 9092398
[TBL] [Abstract][Full Text] [Related]
39. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.
Podbregar M; Voga G
J Card Fail; 2002 Dec; 8(6):369-78. PubMed ID: 12528088
[TBL] [Abstract][Full Text] [Related]
40. Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry.
Nul D; Zambrano C; Diaz A; Ferrante D; Varini S; Soifer S; Grancelli H; Doval H;
Cardiovasc Drugs Ther; 2005 Mar; 19(2):125-34. PubMed ID: 16025231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
